Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 194 for Amyloidosis

Edit search filters
  1. Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

    Rochester, MN

  2. Light Chain Amyloidosis Maintenance Evaluation

    Rochester, MN, Scottsdale/Phoenix, AZ

  3. Experimental Antisense Oligonucleotide Treatment in AA Amyloidosis

    Rochester, MN

  4. Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, Rochester, MN

  5. Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

    Rochester, MN

  6. Research With I-124 EVuzamitide To Elucidate Cardiac AmyLoidosis

    Scottsdale/Phoenix, AZ

  7. A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

    Scottsdale/Phoenix, AZ

  8. A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

    Rochester, MN

  9. TRITON-CM: A Study To Evaluate Nucresiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy

    Rochester, MN

  10. A Study Investigating Coagadex In The Treatment AFXD Associated With AL Amyloidosis

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer